Previous Article | Next Article 
Molecular and Cellular Biology, December 1998, p. 7205-7215, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Identification of a Polar Region in
Transmembrane Domain 6 That Regulates the Function of the G
Protein-Coupled
-Factor Receptor
Peter
Dube1 and
James B.
Konopka2,*
Program in Molecular and Cellular
Biology1 and
Department of Molecular
Genetics and Microbiology,2 State
University of New York, Stony Brook, New York 11794-5222
Received 22 June 1998/Returned for modification 17 July
1998/Accepted 10 September 1998
 |
ABSTRACT |
The
-factor pheromone receptor (Ste2p) of the yeast
Saccharomyces cerevisiae belongs to the family of G
protein-coupled receptors that contain seven transmembrane domains
(TMDs). Because polar residues can influence receptor structure by
forming intramolecular contacts between TMDs, we tested the role of the
five polar amino acids in TMD6 of the
-factor receptor by mutating
these residues to nonpolar leucine. Interestingly, a subset of these
mutants showed increased affinity for ligand and constitutive receptor activity. The mutation of the most polar residue, Q253L, resulted in
25-fold increased affinity and a 5-fold-higher basal level of signaling
that was equal to about 19% of the
-factor induced maximum signal.
Mutation of the adjacent residue, S254L, caused weaker constitutive
activity and a 5-fold increase in affinity. Comparison of nine
different mutations affecting Ser254 showed that an S254F
mutation caused higher constitutive activity, suggesting that a large
hydrophobic amino acid residue at position 254 alters transmembrane
helix packing. Thus, these studies indicate that Gln253 and
Ser254 are likely to be involved in intramolecular
interactions with other TMDs. Furthermore, Gln253 and
Ser254 fall on one side of the transmembrane helix that is
on the opposite side from residues that do not cause constitutive
activity when mutated. These results suggest that Gln253
and Ser254 face inward toward the other TMDs and thus
provide the first experimental evidence to suggest the orientation of a
TMD in this receptor. Consistent with this, we identified two residues
in TMD7 (Ser288 and Ser292) that are potential
contact residues for Gln253 because mutations affecting
these residues also cause constitutive activity. Altogether, these
results identify a new domain of the
-factor receptor that regulates
its ability to enter the activated conformation.
 |
INTRODUCTION |
The
-factor mating pheromone
receptor that promotes the conjugation of the yeast Saccharomyces
cerevisiae belongs to the large family of G protein-coupled
receptors (GPCRs) (13). Receptors in this family transmit
the signals for a wide range of stimuli, including light, hormones, and
neurotransmitters (63). GPCRs function in a similar manner
because they transduce their signal across the plasma membrane by
activating a heterotrimeric guanine nucleotide binding protein (G
protein) (6). In the case of the pheromone pathway,
identification of the components that transduce the signal has been
greatly facilitated by the genetic accessibility of yeast (15, 36,
37). Interestingly, analysis of these components has demonstrated
that they are remarkably similar to the signaling components in
mammalian cells including the receptors, G protein subunits, an RGS
protein that regulates G protein signaling, protein kinases that form a
mitogen-activated protein kinase (MAP kinase) cascade, and
transcription factors (13, 22, 37).
Although the
-factor receptor and other GPCRs respond to a wide
range of diverse stimuli, it is interesting that they share a common
structural organization in that they are all composed of seven
transmembrane domains (TMDs) that are connected by intracellular and
extracellular loops (6). The functional domains of the
-factor receptor are also similar to other GPCRs. For example, the
core region of the
-factor receptor encompassing the seven TMDs
carries out ligand binding and G protein activation (32, 47,
53). In addition, the third intracellular loop functions in G
protein coupling (11, 49, 58), and the cytoplasmic C
terminus of the
-factor receptor is a target for negative regulation by phosphorylation (10, 16, 24). Unfortunately, GPCRs do not
contain significant sequence similarity across the whole receptor family to help identify the functionally important residues. In spite
of this lack of sequence similarity, many mammalian GPCRs can activate
the pheromone signal pathway if they are expressed in yeast (28,
43, 44). The ability of GPCRs to activate G protein signaling in
such heterologous cell types indicates that there are underlying
similarities in the mechanisms of GPCR activation that can be explored
with the help of the genetic approaches possible in yeast.
The mechanisms of GPCR activation are poorly understood, but several
different approaches indicate that the TMDs play an important role in
signaling. Mutagenesis studies aimed at identifying the functional
domains of GPCRs have shown that the TMDs play a key role in
transducing the signal across the plasma membrane (6, 13).
Biochemical studies indicate that ligand binding induces specific
conformational changes in the TMDs that are associated with the
activated state of the receptors (14, 17, 25). In the case
of the
-factor receptor, a ligand-induced conformational change was
identified by studies which showed that the binding of
-factor to
the receptor increased the accessibility of the third intracellular
loop to protease digestion (7). Analysis of constitutively
active GPCR mutants that signal in a ligand-independent manner suggests
that the effect of ligand binding may be to relieve constraints on
receptor structure and allow for isomerization to the activated
conformation (30, 38, 48, 50). Altogether, these studies
indicate that receptor activation results from a change in the
organization and packing of TMDs (6). However, the
hydrophobic nature of the TMDs has made it difficult to analyze specific structural changes, and the key changes that promote G protein
activation are not known.
Polar residues in TMDs are given special emphasis in models for
receptor function because of their potential to form intramolecular contacts that can determine receptor conformation (2). Polar residues are not usually found in hydrophobic membrane spanning segments, but the polar residues in GPCRs can be shielded from the
nonpolar membrane environment by facing inward toward the other TMDs,
since the seven TMDs of GPCRs are thought to be clustered in a bundle
(46, 61). This arrangement allows some of the polar residues
to form intramolecular contacts between TMDs that can play a key role
in receptor structure. As an example, a salt bridge between residues in
TMD3 and TMD7 of rhodopsin helps to maintain photoreceptors in the
inactive state (48). A polar region at the base of TMD3,
termed the DRY motif, has also been implicated in the function of some
GPCRs (42, 50). However, these domains are not conserved in
all receptors and are not present in the
-factor receptor. In
general, there are only limited data on the function of polar residues
in TMDs, and their function in the
-factor receptor has not been
analyzed. Therefore, we investigated the effects of mutating polar
residues in TMD6 of the
-factor receptor. The polar residues in TMD6
were specifically targeted for analysis, because a previous study
showed that a P258L mutation in TMD6 caused constitutive receptor
activity, indicating that this region of the
-factor receptor is
important for receptor function (33). Furthermore, these
polar residues are mainly located in the cytoplasmic half of TMD6 and
are adjacent to the third intracellular loop of the receptor that
functions in G protein activation. The analysis of the effects of these mutations on ligand binding and G protein signaling in this study identified a novel polar region of TMD6 that plays an important role in
receptor signaling.
 |
MATERIALS AND METHODS |
Strains and media.
The yeast strains used are described in
Table 1. Cells were grown in media
described by Sherman (56). Plasmid-containing cells were
grown in synthetic medium containing adenine and amino acid additives
but lacking uracil to select for plasmid maintenance. Yeast
transformations were performed by the lithium acetate method (52). Deletion of the
-factor genes in strain JKY127-36-1
was accomplished by introducing a
mf
1::LEU2 mutation (35)
and a mf
2::his5+
mutation. In order to create the
mf
2::his5+ allele,
primers that contained 50 bp of homology to the sequences flanking the
M F
2 gene followed by 17 bp flanking the
Schizosaccharomyces pombe his5+ gene in plasmid
pME3 (kindly provided by N. Dean) were used in a PCR with pME3 as the
template. The resulting
mf
2::his5+ DNA was used
to transform his3
S. cerevisiae
cells, and the replacement of MF
2 with
his5+ sequences was selected for by plating
cells on medium lacking histidine, since the S. pombe
his5+ gene will complement a his3 mutation
in S. cerevisiae. Deletions were confirmed by PCR analysis
of the genomic DNA and also by a backcross of this strain which showed
that the combination of the
mf
1::LEU2 and the
mf
2::his5+ mutations
blocked the ability of MAT
cells to produce
-factor.
Mutagenesis of the
-factor receptor gene.
Mutations were
introduced into the
-factor receptor gene (STE2) by PCR.
Taq DNA polymerase and all other PCR reagents were purchased
from Boehringer Mannheim. Plasmid pDB02 (STE2 CEN3 URA3 ARS1) (33) was used as template for all PCRs. Plasmid
pDB02 was constructed by using PCR to add an SphI site 5' of
the STE2 coding region (minus 837 bp) and a SacI
site 3' of the coding region (695 bp downstream) and then inserting the
modified STE2 fragment into pJK67, which was derived from
YCplac33 (18) by destroying the endogenous AatII
site by deleting the 3' overhang. The PCR primers were complementary to
the STE2 sequence, except for the noted codon change
required to introduce the mutation. After PCR, the 276-bp
AatII-ClaI fragment containing the desired change
was subcloned into pDB02 to create ste2-S251L (TCA
CTA), ste2-C252L (TGT
CTT), ste2-Q253L (CAA
CTA),
and ste2-S254L (TCT
CTT). ste2-S259L was
created by first subcloning the 605-bp AatII-PstI fragment of STE2 into the AatII-PstI
sites of pBR322 to create pPD03. A 283-bp
AatII-SspI PCR fragment containing the S259L
(TCG
CTG) change was subcloned into pPD03, and then the 605-bp
AatII-PstI fragment of pPD03 was subcloned into
pDB02 to create ste2-S259L. ste2-S254F was
isolated by genetic screening based on the ability of this mutant to
activate a FUS1-lacZ reporter gene in the absence of
-factor, and then this mutant receptor gene was sequenced to
identify the mutation. The methods used in this genetic screen were
similar to those used previously to isolate the constitutive mutant
STE2-P258L (33). To verify that the S254F
mutation accounted for the constitutive activity, an
AatII-ClaI fragment carrying this mutation was
subcloned into pDB02. Receptor genes containing other mutations at
position 254 were constructed with a heterogeneous PCR primer that
randomly introduced all four bases at the three positions of codon 254. After PCR, the 276-bp AatII-ClaI fragment was
subcloned into pDB02. This pool of mutant plasmids was introduced into
yeast strain JKY78, and then the cells were tested for mating ability.
DNA sequence analysis of receptor plasmids recovered from 18 mating-competent strains that showed constitutive activity identified
nine different substitution mutations at position 254. Mutations that
resulted in the substitution of Ser288, Ser292,
and Ser293 with alanine were constructed with the SURE
CHANGE mutagenesis kit (Stratagene). Plasmid pDB02 was used as the
template for single mutants, and a pSTE2-Q253L plasmid was
used as the template for the double mutants. Mutagenic oligonucleotides
were designed according to manufacturer's instructions and were
complementary to the STE2 sequence, except for the indicated
changes required to change the appropriate serine codon to alanine:
STE2-S288A (TCT
GCT), STE2-S292A (TCA
GCA),
and STE2-S293A (TCA
GCA). Plasmids with STE2
under the control of the galactose-inducible GAL1 promoter were created by subcloning the 605-bp AatII-PstI
fragment from each of the mutants into pJK57. pJK57 was constructed by
using PCR to add a BamHI site to the 5' end of the
STE2 open reading frame and a SacI site to the 3'
end so that it could be cloned into pCTG2 downstream of the
GAL1 promoter. pCTG2 was a gift from Phil James and contains
a 690-bp EcoRI-BamHI fragment containing the
GAL1 promoter inserted into pRS314 (57). All of
the mutations constructed in this study were confirmed by dideoxy
sequencing of the double-stranded DNA with Sequenase (U.S. Biochemical).
-Factor receptor analysis.
Western immunoblots were
carried out essentially as described elsewhere (32).
Mid-logarithmic-phase cells (2.5 × 108) were
harvested and lysed by agitation with glass beads in 250 µl of lysis
buffer (2% sodium dodecyl sulfate [SDS], 100 mM Tris [pH 7.5], 8 M
urea). A 100-µg amount of protein extract, as determined by the
bicinchoninic acid protein assay kit (Pierce), was separated by
electrophoresis on an 10% SDS-polyacrylamide gel, electrophoretically transferred to nitrocellulose, and probed with rabbit anti-Ste2p antibodies (32). Immunoreactive proteins were detected by
chemiluminescence with an ECL kit (Amersham).
-Factor binding assays
were conducted essentially as described elsewhere (49).
Logarithmic-phase cells were collected by centrifugation, washed twice
with ice-cold inhibitor medium (IM; YEPD medium containing 10 mM KF and
10 mM NaN3), and resuspended at a density of
109 cells/ml. A 50-µl volume of cells was mixed with 50 µl of 35S-
-factor and incubated for 30 min, and then
the cells were collected on a Whatman GF/C filter and the unbound
-factor was removed by washing. Nonspecific binding was determined
by performing reactions in the presence of a 100-fold excess of cold
-factor. Scatchard plots represent the averages of three to six
independent assays done in duplicate. Similar results were obtained
when the data were plotted by the method of Klotz (31).
35S-labeled
-factor was purified from the supernatant of
MAT
cells labeled with [35S]SO4
by chromatography on a Bio-Rex 70 column as described previously (49).
-Factor-induced responses.
To examine the ability of
cells to mate, patches of yeast strain JKY78 carrying the indicated
STE2 allele on a plasmid pJK67 were replica plated to YPD
plates containing a lawn of MAT
cells (lys1
). The
cells were incubated at 30°C for 12 h to allow mating and were
then replica plated to minimal plates lacking amino acids, incubated at
30°C for 48 h to select for the growth of diploids, and then
photographed. Quantitative mating assays were performed by mixing
3 × 106 lys1
cells with various dilutions of
MATa cells containing the indicated mutant receptor
plasmids on a synthetic medium plate lacking lysine. The plates were
incubated at 30°C for 72 h, and then efficiency of mating was
determined by counting the number of diploid colonies that were formed
at each dilution of cells. To assay induction of FUS1-lacZ
in far1
cells, cultures were grown overnight
to logarithmic phase in selective medium, diluted to 4 × 106 cells/ml and incubated with the indicated
concentrations of synthetic
-factor (Bachem) for 2 h.
Inductions were stopped by adding cycloheximide (final concentration,
10 µg/ml), and then
-galactosidase assays were performed by
using the colorimetric substrate
O-nitrophenyl-
-D-galactopyranoside (ONPG) as
described elsewhere (41). Basal levels of
FUS1-lacZ expression were determined as described above,
except that the cells were incubated in the absence of
-factor. To
assay the effects of galactose-induced expression of receptor mutants,
the cells were first grown overnight in synthetic medium containing raffinose and diluted to 4 × 106 cells/ml, galactose
was added to the medium at a final concentration of 2%, and then after
a 5-h incubation the cells were assayed for FUS1-lacZ
induction as described above. Induction of FUS1-lacZ was
assayed in ste5-3ts cells (JKY79) that were
grown overnight to logarithmic phase in selective medium at 34°C
which was adjusted to 2.5 × 106 cells/ml and then
shifted to 23°C for 8 h.
-Factor was added to a final
concentration of 10
6M to induce signaling in the
wild-type cells. Inductions were stopped by adding cycloheximide (final
concentration, 10 µg/ml), and then
-galactosidase assays were
performed in duplicate with the colorimetric substrate chlorophenyl
red-
-D-galactopyranoside (CPRG). The results of at least
two independent assays, each done in duplicate, are reported.
 |
RESULTS |
Mutation of polar residues in TMD6.
Our previous studies
implicated TMD6 in
-factor receptor activation because a mutation of
Pro258 to Leu (P258L) in TMD6 caused constitutive receptor
activity in the absence of
-factor (33). To analyze the
mechanisms of receptor activation further, we screened for additional
constitutive mutations and identified another mutation in TMD6, S254F,
that also caused constitutive signaling (see Materials and Methods). Interestingly, Ser254 is one of five polar residues found
in TMD6 that may interact with the other TMDs to influence receptor
structure. Therefore, the function of the polar amino acids in TMD6 of
the
-factor receptor was examined by mutating the corresponding
codons in the receptor gene (STE2) to leucine codons by
site-directed mutagenesis (see Materials and Methods). As shown in Fig.
1, the most polar amino acids in TMD6
include Ser251, Cys252, Gln253,
Ser254, and Ser259. In addition, we also
studied the ste2-S254F mutant that was isolated by genetic
screening for constitutive
-factor receptor mutants. To confirm that
the mutant receptor proteins were produced, the plasmids carrying the
mutant receptor genes were introduced into a yeast strain (JKY78)
lacking the wild-type STE2 gene, and then cell extracts were
analyzed by Western blotting (Fig. 2). As
expected, the wild-type receptor protein (Ste2p) was detected as
multiple bands on Western blots due to the N-linked glycosylation of
the receptor (4). The mutant receptor proteins displayed a
similar heterogeneous pattern, indicating that they entered the
secretory pathway efficiently. All of the mutants appeared to produce
similar levels of receptor protein, which was slightly less than the
wild-type level.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
Polar residues in TMD6 of the -factor receptor. The
predicted two-dimensional topology of the receptor in the plasma
membrane, with the extracellular domain at the top, is shown. The
expanded view of TMD6 details the relative positions of amino acid
residues. The polar amino acid residues investigated in this study are
in boldface.
|
|

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
Immunoblot analysis of mutant receptor proteins.
Extracts of yeast strain JKY78 carrying the indicated wild-type or
mutant STE2 allele on plasmid vector pJK67 were separated by
electrophoresis on an SDS-polyacrylamide gel, transferred to
nitrocellulose, and probed with affinity-purified rabbit anti-Ste2p
antibodies (32). Immunoreactive proteins were detected by
chemiluminescence. The relative molecular weights of prestained
molecular weight markers (BioRad) are noted to the left.
|
|
Ligand responsiveness of mutant receptors.
The overall ability
of the mutant receptors to function was assessed by examining the
mating ability of JKY78 cells carrying the mutant STE2 genes
on plasmids. As shown in Fig. 3,
MATa cells carrying the wild-type STE2 gene
mated with MAT
cells, as evidenced by formation of
diploid cells that grew on selective medium. Similarly, all of the
cells carrying mutant receptor genes mated. Some of the mutant strains
appeared to mate poorly compared to wild type; thus, quantitative
mating assays were carried out (Fig. 3). Of the group, the
ste2-S259L mutant mated the most poorly, with an efficiency
of 1.4% of that of the wild type. The ste2-S251L and
-S254F mutants mated with slightly better efficiency (7.5 and 5.4%, respectively), and the other mutants (ste2-C252L,
-Q253L, and -S254L) mated essentially as well as
the wild type. Thus, all of the mutants are at least partially
functional to carry out the full range of receptor activities.

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 3.
Mating efficiencies of receptor mutants. Mating
abilities were tested by replica plating patches of
MATa strain JKY78 carrying the indicated wild-type or
mutant STE2 allele on plasmid vector pJK67 to a lawn of
MAT cells (lys1 ). After the cells were allowed to
mate, they were replica plated to selective plates for 2 days at
30°C, and then the growth of diploid cells that were formed by mating
was photographed. Mating efficiencies are expressed as a percentages of
wild type as determined by quantitative mating analysis.
|
|
To examine the function of the mutant receptors in more detail,
dose-response assays were carried out to quantify their ability to
induce a reporter gene in response to
-factor. This analysis was
also carried out in the JKY78 yeast strain, because it carries a
pheromone-responsive FUS1-lacZ reporter gene (60)
that provides a quantitative assay for the induction of signaling. As
shown in Fig. 4, the
ste2-S251L, -C252L, -Q253L, and
-S254L mutants could be induced to approximately the same
maximum level as wild-type cells when treated with a dose of
-factor
that is essentially saturating for wild type (10
7M). The
exceptions were the ste2-S254F mutant, which was induced only to about 80% of the maximum wild-type level, and the
ste2-S259L mutant, which was induced only to about 20% of
the maximum. Although some mutants were partially defective, these
results indicate that none of the polar residues in TMD6 were
absolutely required for the receptors to respond to
-factor.
Interestingly, the ste2-Q253L and -S254F mutants
displayed an increased level of basal signaling that demonstrates a
role for these residues in preventing spontaneous activation of the
receptor in the absence of
-factor (Fig. 4A). The constitutive
activity of the mutant receptors will be described in detail below.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Ligand-dependent activation of a FUS1-lacZ
reporter gene by mutant receptors; dose-response assays for yeast
strain JKY78 carrying the indicated wild-type (WT) or mutant
STE2 allele on plasmid vector pJK67. Logarithmic-phase cells
were incubated with the indicated concentrations of -factor for
2 h and then assayed for -galactosidase activity to measure the
induction of the pheromone-responsive FUS1-lacZ reporter
gene. The results represent two to six independent assays, each done in
duplicate. The standard deviation was less than 8% for all data
points. (A) Results for the ste2-Q253L and -S254F
mutants; (B) results for the ste2-S251L, -C252L,
-S254L, and -S259L mutants.
|
|
Ligand-binding properties of mutant receptors.
Radioligand-binding assays were performed to determine whether
mutations affecting the polar residues altered the ligand-binding properties. Ligand binding is a sensitive measure of the structure of
mutant receptors, because the
-factor binding pocket is formed by
the region of the receptor that contains the seven TMDs.
Equilibrium-binding assays were carried out on whole cells with
35S-labeled
-factor, and then the data were analyzed by
the Scatchard method. Scatchard plots for the wild type and the mutants
that had the strongest effect on binding (ste2-Q253L and
-S254F) are shown in Fig. 5.
Binding data for the wild type and for all of the mutants are
summarized in Table 2. The
Kd for wild-type receptors was 10 nM, which is
in agreement with previous studies (27, 33). Interestingly,
the mutants all bound
-factor with an affinity equal to or greater
than that of the wild-type receptors. The mutation affecting the most
polar residue in TMD6, Q253L, had the strongest effect on binding. The
Kd for the binding of
-factor to
ste2-Q253L cells was 25-fold lower than that for wild-type cells, indicating that these cells have significantly increased affinity for
-factor. The mutations affecting Ser254
also increased binding affinity: the ste2-S254F and the
ste2-S254L mutants showed 11- and 5-fold increased
affinities, respectively. The ste2-S259L mutant displayed
3.7-fold increased affinity, and the ste2-S251L and
-C252L mutants bound
-factor with about the same affinity
as that of the wild type. Thus, none of the polar residues were
essential for ligand binding, and, in fact, binding affinity was
improved in some mutants. Increased binding affinity for the mutant
receptors is interesting, because an increase in binding affinity is
often associated with the activated conformation of GPCRs (5, 38,
50).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 5.
Radioligand-binding studies. Scatchard plot analysis of
wild-type (A), Q253L (B), and S254F (C) receptors. Equilibrium binding
studies were carried out by measuring the binding of
35S- -factor to strain JKY78 carrying the indicated
wild-type or mutant STE2 allele on plasmid vector pJK67. The
small upper panels are plots of the bound versus the free -factor
under the conditions used. The lower panels show the results plotted by
the Scatchard method. Lines, best fits of the data determined by the
least-squares method; data points, averages of three to eight
independent assays, each done in duplicate.
|
|
To assess the efficiency of receptor function further, the
Kd for binding was compared to the abilities of
the mutant receptors to be stimulated by
-factor. To facilitate this
comparison, the dose-response curves shown in Fig. 4 were analyzed to
determine the ligand concentration that gave the half-maximal induction (EC50) of the reporter gene (Table 2). The EC50
for the wild type was 3.5 nM, which corresponds well with the
dissociation constant for
-factor binding (Kd = 10 nM). The ste2-Q253L and -S254F mutants
showed EC50s of 0.5 and 1.2 nM, respectively, indicating a
greater sensitivity to
-factor for these mutants. This increased sensitivity correlates well with the increased affinity of these mutants for
-factor described above. The EC50s for the
other mutants were within twofold of the wild type value. Even the
S254F and S259L mutants that were not able to give the same maximum level of induction as the wild type showed EC50s that were
less than or equal to that of the wild type. These results demonstrate that mutation of a subset of the polar residues in TMD6 causes a
coordinate increase in the binding and signaling of the
-factor receptor.
Radioligand binding studies were also used to determine the number of
cell surface receptors (Table 2). The maximum binding value obtained by
Scatchard analysis indicated that wild-type cells contained
approximately 11,000 receptors, as expected (27, 33). In
contrast, all of the mutants contained fewer cell surface-binding sites. The mutation affecting the most polar residue in TMD6 again had
a strong effect, since the number of receptors was reduced by about
65-fold in the ste2-Q253L mutant. The effects of mutating the adjacent Ser254 codon varied with the substituted amino
acid, since the ste2-S254F mutant showed more than 100-fold
fewer cell surface binding sites and the ste2-S254L mutant
was decreased only by about 5-fold. The magnitude of the decrease in
receptor number did not correlate with the altered affinity of the
mutant receptors, because the ste2-S259L mutant, which
showed a relatively minor increase in affinity, contained about 70-fold
fewer surface receptors. Furthermore, the ste2-S251L and
-C252L mutants did not display a significant change in
affinity, and yet they contained 14- and 5-fold decreased receptor
numbers, respectively. The decreased cell surface expression may be a
result of less efficient transport to the cell surface, as has been
observed for other mutant receptors (26, 59), or of
decreased stability of receptors at the cell surface, since some of the
mutants may mimic the ability of ligand binding to promote rapid
endocytosis of
-factor receptors (23, 49). The
observation that the decreased surface receptor number did not prevent
the detection of signaling by the mutant receptors is consistent with
previous studies indicating that the number of receptors is not
limiting for signaling in wild-type cells (32, 54).
Constitutive receptor activity.
The dose-response assays shown
in Fig. 4 indicated that at least two of the mutants,
ste2-Q253L and -S254F, displayed elevated levels
of basal signaling. To facilitate the analysis of this ligand-independent signaling activity, plasmids containing mutant receptor genes were transformed into a yeast strain (JKY79) that carries a temperature-sensitive mutation in a postreceptor component of
the pheromone signaling pathway, ste5-3ts
(21). This strain also carries a pheromone-responsive
FUS1-lacZ reporter gene and lacks the chromosomal copy of
the receptor gene to prevent interference from the wild-type receptors.
The advantage of incorporating the ste5-3ts
mutation into the strain is that it allows for propagation of the cells
without activation of the pheromone pathway by growing the cells at the
restrictive temperature (34°C), at which there is essentially no
basal activation of the FUS1-lacZ reporter gene. The
pheromone signal pathway can then be made competent by shifting the
cells to the permissive temperature (23°C). When the
ligand-independent activation of the FUS1-lacZ reporter gene
was determined at 23°C, two of the mutants, ste2-Q253L and
-S254F, displayed significantly elevated basal levels of
signaling (Table 3). The basal activity of ste2-Q253L was elevated by about 5-fold, and that of
ste2-S254F was elevated 2.4-fold compared to the wild type.
The ste5-3ts strain was then used to compare the
ligand-independent constitutive signaling of the mutant receptors to
the ligand-induced activity of wild-type receptors. For this
comparison, cells carrying the wild-type receptor were shifted to the
permissive temperature in the presence of a saturating dose of
-factor (10
6 M) to determine the maximum level of
FUS1-lacZ activation. This level of activity was then
compared to the basal signaling activity in the receptor mutant strains
in the absence of
-factor. As shown in Table 3, the basal activity
of ste2-Q253L was equivalent to about 19% of the maximum
ligand-induced level, and the basal level of ste2-S254F was
equivalent to about 10% of the maximum. This level of signaling
activity is comparable to those of the previously identified
constitutive mutants, STE2-P258L and
STE2-P258L-S259L, whose basal signaling activities were
equivalent to about 12 and 45%, respectively, of the ligand-induced
maximum (33). These results indicate that the Q253L and
S254F mutations affect the structure of the receptor so as to partially
mimic the activated conformation of the receptor. Thus, a subset of the
polar residues in TMD6 is required to prevent receptors from entering
the activated conformation in the absence of ligand.
To examine whether the number of receptors was limiting for detection
of constitutive signaling, we tested the effects of overproducing the
mutant receptors. For this analysis, we introduced the mutant receptor
genes into cells on multicopy plasmid vectors, and in separate studies
we also placed the mutant receptor genes under control of a strong
galactose-inducible GAL1 promoter that results in
approximately 30-fold overproduction of receptors. The results showed
that overproduction did not help to reveal constitutive activity for
the other receptor mutants and had only small positive effects on the
basal levels of signaling for the ste2-Q253L and
-S254F mutants (data not shown).
Basal levels of signaling in an sst2
adaptation-defective strain.
In order to gain increased
sensitivity for the analysis of the basal signaling by the mutant
receptors, we analyzed the effects of the mutants in an
adaptation-defective sst2-1 strain. These cells are more
sensitive to
-factor because of the inability of Sst2p to regulate
the pheromone-responsive G
subunit (1, 8). To
help maintain a low basal level of signaling in these cells, the genes
encoding
-factor were deleted. This prevents the rare cells that
switch mating type from producing
-factor that could otherwise
stimulate this supersensitive strain. The cells also carry a mutation
in the FAR1 gene to prevent pheromone-induced cell division
arrest (9). Analysis of the ste2-Q253L and
-S254F mutants in this strain showed that they both caused
greater than a 10-fold increase in the basal level of signaling (Fig.
6). These results demonstrate that the
elevated basal level of signaling by these mutants is not due to
autocrine signaling, because the
-factor genes are deleted from this
strain. Furthermore, the detection of elevated basal signaling by the
ste2 mutants in an sst2
strain
shows that the constitutive receptor activity is independent of
SST2 and is not a consequence of a defect in
SST2-mediated adaptation. Interestingly, the
ste2-S254L mutant showed a readily detectable sixfold
increase in basal signaling in this sst2
strain that was not obvious in the SST2+ strain.
The elevated level of basal signaling detected for the ste2-S254L mutant in this strain demonstrates that the
sst2-1 mutation had the predicted effect of increasing the
sensitivity of the assay. In spite of this, the other receptor mutants
(ste2-S251L, -C252L, and -S259L) did
not show a significant increase in basal activity. These results
demonstrate that in comparison to the other polar residues in TMD6,
Gln253 and Ser254 play a special role in
receptor function.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of the basal signaling levels by receptor
mutants in an sst2 adaptation-defective strain.
Supersensitive sst2-1 strain JKY127-36-1 carrying the
indicated wild-type or mutant STE2 allele on plasmid vector
pJK67 was assayed for -galactosidase activity to measure the basal
level of the pheromone-responsive FUS1-lacZ reporter gene in
the absence of added -factor. The results are averages of two
independent assays done in duplicate (± standard deviations).
|
|
Effects of different substitution mutations at residue 254.
The observation that substitution of Ser254 with Phe caused
greater constitutive activity than substitution with Leu suggested that
the type of amino acid substituted at position 254 could influence the
degree of constitutive activity. To examine this in more detail,
site-directed mutagenesis was used to introduce all possible codon
combinations at this position, and then the pool of mutant receptor
plasmids was introduced into yeast cells for analysis (see Materials
and Methods). Yeast colonies that contained functional receptors were
identified by testing for mating ability, and then nine different
constitutive mutations were identified after sequencing 18 independent
isolates. The basal level of signaling was at least slightly increased
in all of the mutant strains (Fig. 7).
Substitution of Ser254 with Ala, Asp, Val, Gln, or Tyr all
caused about a 2-fold increase in the basal level of signaling,
indicating that the loss of serine at position 254 promoted higher
basal levels of signaling. Higher levels of basal signaling (3- to
7.5-fold) were observed when Ser254 was substituted with
Gly, Leu, Phe, or Trp, indicating that the insertion of these residues
caused an additional effect on constitutive signaling. All of the
mutants with nonaromatic amino acids at residue 254 (Gly, Ser, Ala,
Asp, Val, Gln, and Leu) displayed the ability to maximally induce a
reporter gene (Fig. 4 and data not shown), indicating that these
receptors were not obviously impaired in signaling. However,
substitution of Ser254 with aromatic amino acids (Phe, Tyr,
or Trp) resulted in a partial defect in
-factor-induced signaling
(Fig. 4 and data not shown), indicating that the substitution of
Ser254 with these larger amino acids altered receptor
structure in a way that also adversely affected G protein activation.
Thus, the basal signaling activity of this latter group of mutants may
be slightly lower than might otherwise be expected based on the
correlation with the type of amino acid substituted at position 254 (see Discussion). Altogether, the differential abilities of the various
substitution mutants to promote ligand-independent activation of the
receptor indicate that Ser254 is located within a region of
the receptor that can alter the structure of the TMDs in a way that
mimics the activated state of the receptor.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 7.
Constitutive signaling activity of Ser254
substitution mutants. Strain JKY127-36-1 carrying the wild-type
STE2 allele or the indicated substitution mutations
affecting Ser254 on plasmid vector pJK67 was assayed for
-galactosidase activity in the absence of -factor to determine
the basal levels of the pheromone-responsive FUS1-lacZ
reporter gene. The different mutants are listed in order of increasing
size of the residue substituted at position 254. Results are fold
increases in basal activity over that of the wild type and are the
averages of two independent assays, each done in duplicate (± standard
deviations).
|
|
Analysis of potential contact residues.
The phenotypes caused
by mutations affecting Gln253 and Ser254
suggest that these residues may form important contacts with the other
TMDs. Inspection of the
-factor receptor sequence indicates that
there are more than 40 residues in the predicted TMDs that may be
capable of forming hydrogen bond interactions. As an approach to
identifying potential contact residues for Gln253 and
Ser254, we reasoned that mutations affecting the contact
residues should cause constitutive activity similar to the effects of
mutating Gln253 and Ser254. To focus our
efforts on identifying residues that may contact TMD6, we analyzed the
effects of mutating the polar residues in TMD5 and TMD7, since they are
likely to be adjacent to TMD6 in the receptor (2). In
addition, we further narrowed our analysis to examining the effects of
mutating the residues in the cytoplasmic halves of TMD5 and -7 that are
likely to be in a position to interact with either Gln253
or Ser254 in TMD6.
Analysis of the three polar residues in the cytoplasmic half of TMD7
(Ser288, Ser292, and Ser293) was
carried out by mutating the corresponding codons to alanine (see
Materials and Methods). The only polar residue in the cytoplasmic half
of TMD5 (Lys225) was previously mutated to Cys as part of a
separate study in our lab and found not to display significant
constitutive activity (unpublished data), although it should be noted
that these studies were carried out with different plasmid vectors and
yeast strains. In contrast, the ste2-S288A mutant and the
ste2-S292A mutants displayed about 3- and 4.5-fold increased
basal signaling activities, respectively, in the
sst2
strain (JKY127-36-1) (Fig.
8A). The constitutive activity was specific to these mutants, since the ste2-S293A mutant did
not display elevated basal levels of signaling. The mutations affecting the three serine residues in TMD7 did not appear to cause deleterious effects on receptor signaling, because the mutant strains could induce
a FUS1-lacZ reporter gene to maximum levels when treated with
-factor (Fig. 8B). Furthermore, these receptor mutants also showed EC50s similar to that for the wild type for
induction of the reporter gene (not shown). These results demonstrate
further that a specific subset of the polar residues in the
-factor
receptor is required to prevent ligand-independent receptor activation.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 8.
Mutational analysis of polar residues in TMD7. Strain
JKY127-36-1 carrying the indicated wild-type or mutant STE2
allele on plasmid vector pJK67 was assayed for -galactosidase
activity to determine the relative levels of the pheromone-responsive
FUS1-lacZ reporter gene. Cells were assayed in the absence
of -factor (A) and in the presence of 10 6 M -factor
(B) to determine the basal and pheromone-induced levels, respectively.
The results are the averages of two independent assays, each done in
duplicate (± standard deviations).
|
|
Since we predict that Gln253 may face in the direction of
TMD7 (see Discussion), it is possible that the Ser288 and
Ser292 residues may contact Gln253. This
contact could be stabilized by hydrogen bond formation with the
hydroxyl groups on the serine side chain acting as hydrogen bond donors
and the oxygen on the glutamine side chain acting as an acceptor.
Therefore, we carried out double mutant analysis to help determine the
relationship between the mutations affecting Gln253 and the
three serine residues in TMD7. The rationale for this approach was that
the effects of two different constitutive receptor mutations should not
be additive if they affect the same receptor contact and should have
additive effects if they affect different intramolecular contacts. The
results of this analysis showed that none of the double mutant
combinations displayed significantly greater basal signaling activity
than the ste2-Q253L mutant alone (Fig. 8A). Two of the
double mutants, ste2-Q253L-S292A and
ste2-Q253L-S293A, showed basal activity that was slightly
lower than that of the ste2-Q253L single mutant. This lower
basal level of signaling did not appear to be due to a defect in
receptor signaling, because all of the double mutants could be induced
efficiently with
-factor (Fig. 8B and data not shown). Thus, the
failure of the S288A and S292A mutations to further increase the
constitutive activity caused by the Q253L mutation identifies
Ser288 and Ser292 as potential contact residues
for Gln253.
 |
DISCUSSION |
In order to gain insight into the mechanisms of GPCR activation,
we investigated the effects of mutating the polar residues in TMD6 of
-factor receptor. The function of polar residues was examined
because they have the ability to form contacts between TMDs that can
play a key role in receptor structure. We focused on the polar residues
in TMD6 because of the previous identification of constitutive receptor
mutations in this domain. Also, TMD6 is adjacent to the third
intracellular loop that plays a key role in G protein activation. The
mutant receptor proteins were produced at levels similar to that for
the wild type and were glycosylated, indicating that they enter the
secretory pathway efficiently. However, the mutant cells contained
fewer surface receptors for
-factor than wild-type cells. This
decrease in cell surface receptors suggests that the mutations
affecting the polar residues altered receptor structure in a way that
was recognized by the mechanisms that control the trafficking of
receptors to or from the plasma membrane (23, 26, 59). The
decrease in receptor number was not so high as to prevent detection of
receptor signaling, because all of the mutant receptors showed at least
partial ability to respond to
-factor. Evolutionarily conserved
polar residues in TMDs are often given special emphasis in molecular
models for receptor function (2, 3), so it is worth noting
that two of the polar residues in TMD6 (Ser251 and
Gln253) are conserved in the pheromone receptors from
Saccharomyces kluyveri (40) and
Schizosaccharomyces pombe (29). Mutations affecting Gln253 had significant effects on ligand binding
and signaling. In contrast, mutations affecting Ser251 did
not appear to alter receptor function aside from lowering the number of
cell surface binding sites. This indicates that some conserved polar
residues, such as Ser251, may be more important for proper
receptor production than for signal transduction.
Effects on ligand binding.
Previous studies have shown that
-factor binding is mediated by the central region of the
-factor
receptor that contains the TMDs (32, 47). Studies of
chimeric receptors formed between the
-factor receptors from
S. cerevisiae and S. kluyveri further indicate
that ligand binding is carried out by noncontiguous domains within this
central region (39, 53). It was, therefore, very interesting
that mutating the most polar residue in TMD6 to Leu (Q253L) resulted in
25-fold increased binding affinity. A mutation affecting the adjacent
Ser254 residue (S254L) also caused a significant increase
in affinity (5-fold). The mutated residues are unlikely to be directly
involved in ligand binding, because two different substitutions at
position 254 (S254L and S254F) both increased binding affinity.
Instead, these results suggest that the mutated residues influence
binding affinity indirectly by altering the packing of the TMDs.
Increased binding affinity may result from the abilities of these
mutants to mimic the activated state of the receptor, because they also displayed constitutive receptor activity. Many GPCRs display increased affinity for ligand when they are coupled to a G protein; thus, it has
been suggested that the increased affinity of constitutive mutants is
due to their ability to mimic the activated state of the receptor
(38). Altogether, these results suggest that the polar
residues in TMD6, particularly Gln253 and
Ser254, influence the packing of the TMDs in a way that
affects the ligand binding pocket.
Effects on constitutive signaling.
Mutations affecting a
subset of the polar residues in TMD6 also altered receptor structure in
a way that caused higher basal levels of signaling in the absence of
-factor. In particular, mutation of the Ser254 and
Gln253 residues increased basal signaling. To examine the
strength of this constitutive receptor activity, we made use of an
ste5ts strain (Table 3) so that we could compare
the levels of constitutive signaling by the mutants with the maximum
levels of
-factor-induced signaling by wild-type receptors. In these
studies, we found that, in the absence of
-factor,
ste2-Q253L signaled at 19% and ste2-S254F signaled at about 9% of the ligand-induced maximum. The
ste2-S254L mutant displayed weaker constitutive activity
that was not readily detected in the ste5ts
strain, but in a supersensitive sst2
strain
the ste2-S254L receptors increased basal signaling by about
fivefold above that of background. In contrast, the basal signaling
levels were not significantly increased by the ste2-S251L, -C252L, or -S259L mutant receptors, even in a
supersensitive strain. These results indicate that Gln253
and Ser254 in TMD6 play a special role in stabilizing
receptors in the inactive conformation and in preventing constitutive
activity in the absence of ligand.
The observation that substituting Ser254 with Phe caused
stronger constitutive activity than substitution with Leu suggested that the character of the residue at position 254 had significant effects on receptor structure and function. Therefore, we examined a
set of nine different substitution mutations at residue 254. All of the
mutants showed at least slightly elevated basal signaling. The simple
loss of the Ser254 hydroxyl group was not sufficient to
cause strong constitutive activity, because substitution with Ala
caused only about a twofold increase in basal signaling. Substitution
of a more hydrophobic amino acid at residue 254 was also not
sufficient, because Val had much weaker effects than Leu. The residues
that resulted in the most significant degree of constitutive activity
when substituted at position 254 were Gly, Leu, Phe, and Trp. It was
interesting that three of these residues are larger than ser (Leu, Phe,
and Trp). This suggested that there might be some similarities between the activation of the
-factor receptor and rhodopsin, because studies of rhodopsin indicate that TMD3 and -6 move apart during activation (14). Furthermore, certain substitution mutations that introduce larger amino acid residues into TMD3 of rhodopsin affect
the positioning of the retinal chromophore in a way that causes higher
basal levels of signaling in the dark (20). However, substitution of Ser254 with Gly, the smallest amino acid,
also gave high levels of constitutive activity for the
-factor
receptor. This indicates either that the size of the residue at
position 254 is not related to constitutive activity, or that Gly at
position 254 alters transmembrane packing in a distinct way to cause
constitutive activity. Nonetheless, the differential effects on basal
signaling caused by the different substitution mutants demonstrate that
Ser254 is in a conformationally sensitive region of the
receptor and that the type of residue substituted at 254 strongly
influences the structure of the receptor.
Orientation of TMD6.
The effects of mutating
Gln253 and Ser254 described above, as well as
the previously described effects of mutating Pro258
(33), indicate that these residues in TMD6 play a special
role in the structure of the
-factor receptor. To examine the
potential significance of these residues further, the amino acids of
TMD6 were displayed on a helical wheel projection to predict their orientation in an
-helix, as shown in Fig.
9. TMD6 of the
-factor receptor is
assumed to form an
-helix similar to those of the TMDs in rhodopsin
and other GPCRs (2, 61). Consistent with this, a synthetic
peptide corresponding to the sequence of TMD6 exhibited helical
character (45). Interestingly, the residues in TMD6 that
cause constitutive activity when mutated (Gln253,
Ser254, and Pro258) are predicted to reside on
one side of the transmembrane helix. In contrast, the polar residues
that did not cause constitutive activity when mutated to leucine
(Ser251, Cys252, and Ser259) all
lie on the opposite side of TMD6. This alignment indicates that the
side of TMD6 containing Gln253 and Ser254 is
likely to be involved in interactions with other TMDs. Furthermore, Gln253 is likely to be facing inward toward the other TMDs,
since it is the most polar residue in TMD6. Thus, the polar nature of
Gln253 and Ser254 and the phenotypes caused by
mutations that affect these residues indicate that they are likely to
face inward toward the other TMDs and to be in a position to have
cooperative effects on the packing arrangement of the other TMDs.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 9.
Helical wheel diagram of TMD6. The residues of TMD6 are
plotted on a helical wheel diagram to display their relative
orientations in an -helix as viewed from the cytoplasmic side of the
plasma membrane. Polar residues that were mutated as part of this study
are boxed. Pro258 is also boxed, because a
ste2-P258L mutation was identified previously as causing
constitutive activity (33). The black boxes with white
letters identify the residues that caused constitutive activation of
the receptor when they were mutated to leucine. Interestingly, these
residues were all located on one side of the helical wheel as shown.
The white boxes with black letters on the opposite side of the wheel
identify the residues that did not cause constitutive activity when
they were mutated to leucine. Although proline residues can perturb the
structure of an -helix, Pro258 is not expected to cause
a significant change in the relative orientations of the residues in
this model, because proline residues are well tolerated in the
transmembrane helices of membrane proteins (19, 62).
|
|
This analysis provides the first experimental evidence to suggest the
orientation of a transmembrane helix in the
-factor receptor; thus,
it was of interest to compare this arrangement with the predicted
structure of the other members of the GPCR family. Based on the
comparison of the sequences of a large set of GPCRs, Baldwin predicted
that the TMDs are arranged in a clockwise manner as viewed from the
intracellular side, as has been determined for rhodopsin (2,
61). Since >90% of GPCRs contain a proline residue in the
middle region of TMD6, this residue forms an important landmark in the
structure of TMD6. In the case of the rhodopsin-adrenergic subfamily of
GPCRs, Baldwin predicted that the conserved proline faces TMD7
(2). In contrast, when the TMDs of the
-factor receptor
are arranged according to Baldwin's model, the orientation of TMD6
predicted above places Pro258 facing generally toward TMD5
in the
-factor receptor. This suggests that although a proline in
TMD6 may be important for a wide range of GPCRs, the relative position
of the proline residue may not be conserved. Perhaps this difference
contributes to the observation that mutating Pro258 causes
strong constitutive activity in the
-factor receptor but not in
other GPCRs (33, 59).
According to the orientation of TMD6 described above,
Gln253 is predicted to face in the direction of TMD7. It
seems likely that significant intramolecular contacts occur between
TMD6 and TMD7 because they are predicted to be adjacent in the Baldwin
model (2). TMD6 and TMD7 are also expected to be in close
proximity because they are connected by a very short extracellular loop (nine amino acids). Therefore, we investigated the possibility that
Gln253 contacts any of the three polar residues in the
cytoplasmic half of TMD7 (Ser288, Ser292, or
Ser293) by mutating each of the corresponding codons to
encode alanine. Interestingly, the ste2-S288A and
-S292A mutants displayed constitutive activity, indicating
that these residues play an important role in receptor structure,
possibly by forming an important contact with Gln253.
Double mutant analysis was also consistent with Gln253
interacting with both Ser288 and Ser292, since
the corresponding double mutants did not display additive effects on
constitutive activity. Contact between these residues could be
stabilized by hydrogen bond interaction, with the serines acting as
hydrogen bond donors and glutamine acting as an acceptor. Furthermore,
Gln253 may be able to interact with both Ser288
and Ser292, since the oxygen in the glutamine side chain
can act as an acceptor to form two hydrogen bonds (12). The
serine residues may also be close enough to simultaneously interact
with Gln253, because Ser288 and
Ser292 are predicted to be in close proximity on the same
side of TMD7, i.e., a little more than one turn apart in an
-helix.
The fact that Gln253, Ser288, and
Ser292 are all conserved in the homologous pheromone
receptors from S. kluyveri (40) and S. pombe (29) also supports the idea that they may form
important intramolecular contacts. We are currently developing
alternative approaches to confirm the identities of the key contact
residues in the receptor to complement the genetic methods used in this study.
Mechanism of receptor activation.
Polar residues have been
implicated in the activation of GPCRs because of their ability to form
intramolecular contacts. In the case of rhodopsin, a salt bridge
between TMD3 and TMD7 is thought to keep rhodopsin in the inactive
conformation until photoactivation of the retinal chromophore leads to
disruption of the salt bridge and subsequent receptor activation. This
mechanism, which is specific for the photoreceptors, was confirmed in
part by showing that mutations affecting the residues that form the
salt bridge caused constitutive signaling in the dark (48).
Another polar region, which is known as the DRY motif, is thought to
play a key role in activation of a broader range of GPCRs, including
the members of the rhodopsin-adrenergic receptor family (42,
50). The DRY motif, which is found at the cytoplasmic end of
TMD3, is proposed to form a polar pocket in conjunction with polar
residues from other TMDs until protonation of the Asp (or Glu) residue
in the DRY motif causes it to move out of the polar pocket and to
permit receptor activation. Consistent with this, certain mutations in this sequence cause constitutive receptor activity and increased affinity for ligand (51). Although this motif is found in
many GPCRs, its absence from the pheromone receptors and other
receptors indicates that additional mechanisms must exist to regulate
receptor activation. In this study, we identified a novel polar region in TMD6 of the
-factor receptor that influences ligand binding and G
protein activation. Since this domain occurs in the cytoplasmic half of
TMD6 adjacent to the third intracellular loop and since the third
intracellular loop is involved in receptor activation, it is expected
that conformational changes in this part of TMD6 can play a significant
role in receptor activation. This aspect of receptor regulation may be
conserved in some of the other GPCRs, because constitutively active
mutations in the luteinizing hormone (55) and the
thyrotropin receptors (34) that are caused by mutation of
polar residues in TMD6 have been discovered. The constitutive activity
caused by these mutations has been implicated in their ability to cause
precocious puberty and hyperfunctioning thyroid adenomas in humans
(34, 55). Thus, analogous polar pockets in TMD6 of other
GPCRs may function in regulation of signaling and consequently may also
be important sites for mutations that cause human diseases.
 |
ACKNOWLEDGMENTS |
We thank Janet Leatherwood and the members of our lab for their
helpful comments on the manuscript. We also thank Phil James and Neta
Dean for plasmids and Diana Murray for help with modeling Ste2p structure.
This work was supported by grants from the American Heart Association
and the National Institutes of Health (GM55107) awarded to J.B.K.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Genetics and Microbiology, State University of New York,
Stony Brook, NY 11794-5222. Phone: (516) 632-8715. Fax: (516) 632-9797. E-mail: konopka{at}asterix.bio.sunysb.edu.
 |
REFERENCES |
| 1.
|
Apanovitch, D. M.,
K. C. Slep,
P. B. Sigler, and H. G. Dohlman.
1998.
Sst2 is a GTPase-activating protein for Gpa1: purification and characterization of a cognate RGS-G protein pair in yeast.
Biochemistry
37:4815-4822[Medline].
|
| 2.
|
Baldwin, J. M.
1993.
The probable arrangement of the helices in G protein-coupled receptors.
EMBO J.
12:1693-1703[Medline].
|
| 3.
|
Baldwin, J. M.,
G. F. Schertler, and V. M. Unger.
1997.
An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors.
J. Mol. Biol.
272:144-164[Medline].
|
| 4.
|
Blumer, K. J.,
J. E. Reneke, and J. Thorner.
1988.
The STE2 gene product is the ligand-binding component of the -factor receptor of Saccharomyces cerevisiae.
J. Biol. Chem.
263:10836-10842[Abstract/Free Full Text].
|
| 5.
|
Blumer, K. J., and J. Thorner.
1990.
and subunits of a yeast guanine nucleotide-binding protein are not essential for membrane association of the subunit but are required for receptor coupling.
Proc. Natl. Acad. Sci. USA
87:4363-4367[Abstract/Free Full Text].
|
| 6.
|
Bourne, H. R.
1997.
How receptors talk to trimeric G proteins.
Curr. Opin. Cell Biol.
9:134-142[Medline].
|
| 7.
|
Bukusoglu, G., and D. D. Jenness.
1996.
Agonist-specific conformational changes in the yeast -factor pheromone receptor.
Mol. Cell. Biol.
16:4818-4823[Abstract].
|
| 8.
|
Chan, R. K., and C. A. Otte.
1982.
Isolation and genetic analysis of Saccharomyces cerevisiae mutants super-sensitive to G1 arrest by a-factor and -factor pheromones.
Mol. Cell. Biol.
2:11-20[Abstract/Free Full Text].
|
| 9.
|
Chang, F., and I. Herskowitz.
1990.
Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of a G1 cyclin, CLN2.
Cell
63:999-1011[Medline].
|
| 10.
|
Chen, Q., and J. B. Konopka.
1996.
Regulation of the G protein-coupled -factor pheromone receptor by phosphorylation.
Mol. Cell. Biol.
16:247-257[Abstract].
|
| 11.
|
Clark, C. D.,
T. Palzkill, and D. Botstein.
1994.
Systematic mutagenesis of the yeast mating pheromone receptor third intracellular loop.
J. Biol. Chem.
269:8831-8841[Abstract/Free Full Text].
|
| 12.
|
Creighton, T. E.
1993.
Proteins. W. H.
Freeman and Co., New York, N.Y.
|
| 13.
|
Dohlman, H. G.,
J. Thorner,
M. G. Caron, and R. J. Lefkowitz.
1991.
Model systems for the study of 7-transmembrane-segment receptors.
Annu. Rev. Biochem.
60:653-688[Medline].
|
| 14.
|
Farrens, D. L.,
C. Altenbach,
K. Yang,
W. L. Hubbell, and H. G. Khorana.
1996.
Requirement of rigid body motion of transmembrane domain helices for light activation of rhodopsin.
Science
274:768-770[Abstract/Free Full Text].
|
| 15.
|
Ferguson, B.,
J. Horecka,
J. Printen,
J. Schultz,
B. J. Stevenson, and G. F. Sprague, Jr.
1994.
The yeast pheromone response pathway: new insights into signal transmission.
Cell. Mol. Biol. Res.
40:223-228[Medline].
|
| 16.
|
Freedman, N. J., and R. J. Lefkowitz.
1996.
Desensitization of G protein-coupled receptors.
Recent Prog. Hormone Res.
51:319-351.
|
| 17.
|
Gether, U.,
S. Lin, and B. K. Kobilka.
1995.
Fluorescent labeling of purified 2 adrenergic receptor. Evidence for ligand-specific conformational changes.
J. Biol. Chem.
270:28268-28275[Abstract/Free Full Text].
|
| 18.
|
Gietz, R. D., and A. Sugino.
1988.
New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites.
Gene
74:527-534[Medline].
|
| 19.
|
Haltia, T.
1997.
Structural features of membrane proteins.
Adv. Mol. Cell. Biol.
22A:229-277.
|
| 20.
|
Han, M.,
J. Lou,
K. Nakanishi,
T. P. Sakmar, and S. O. Smith.
1997.
Partial agonist activity of 11-cis-retinal in rhodopsin mutants.
J. Biol. Chem.
272:23081-23085[Abstract/Free Full Text].
|
| 21.
|
Hartwell, L. H.
1980.
Mutants of Sa |